1. Home
  2. QXO vs FMS Comparison

QXO vs FMS Comparison

Compare QXO & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QXO Inc.

QXO

QXO Inc.

HOLD

Current Price

$25.89

Market Cap

15.6B

Sector

Technology

ML Signal

HOLD

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$24.45

Market Cap

13.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QXO
FMS
Founded
1988
1996
Country
United States
Germany
Employees
N/A
N/A
Industry
EDP Services
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6B
13.9B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
QXO
FMS
Price
$25.89
$24.45
Analyst Decision
Strong Buy
Sell
Analyst Count
13
2
Target Price
$33.17
$30.00
AVG Volume (30 Days)
9.1M
806.4K
Earning Date
03-03-2026
02-24-2026
Dividend Yield
N/A
2.37%
EPS Growth
N/A
8.62
EPS
N/A
2.86
Revenue
$4,662,873,000.00
$23,046,819,198.00
Revenue This Year
$12,060.43
$2.13
Revenue Next Year
$61.19
$2.95
P/E Ratio
N/A
$15.61
Revenue Growth
8107.98
2.10
52 Week Low
$11.85
$20.95
52 Week High
$27.14
$30.46

Technical Indicators

Market Signals
Indicator
QXO
FMS
Relative Strength Index (RSI) 60.86 63.31
Support Level $20.86 $23.74
Resistance Level $23.56 $24.15
Average True Range (ATR) 1.17 0.38
MACD 0.24 0.23
Stochastic Oscillator 74.96 95.33

Price Performance

Historical Comparison
QXO
FMS

About QXO QXO Inc.

QXO Inc is the publicly traded distributor of roofing, waterproofing and complementary building products in the United States. The company aims to become the tech-enabled leader in the approximately $800 billion building products distribution industry and generate outsized value for shareholders. It is targeting nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: